Genmab — Juli 2023
-
Genmab dækkes igen af britiske HSBC: Indleder med "køb"
https://www.proinvestor.com/investornyt/1014971/genmab-daekkes-igen-af-britiske-hsbc-indleder-med-kob -
Euroinvestor siger 3320:-D
-
Det gør Proinvestor også kl. 8.02 i denne chat.
-
Kort video: Det er en lang rejse for selskaber i pharma-bioteksektoren at få et godkendt produkt på markedet. For udviklingsselskaberne i sektoren er det en hård og dyr kamp at finde ny finansiering og vinde investorernes gunst - det mærker mange af selskaberne lige nu. Helge Larsen opridser situationen og ser desuden på den seneste kursudvikling på nogle af de mest populære selskaber på ProInvestor.com. (Genmab,Bava og ZEAL) https://www.proinvestor.com/boards/114014
-
Usa kan godt lide Genmab her til aften. Ligger oppe med 3,25% - svarende til kurs 2654.
-
Det gør det, @ JKY
-
Er lige nu i DH
-
Genmab Breaks Above 200-Day Moving Average - Bullish for GMAB
In trading on Friday, shares of Genmab A/S (Symbol: GMAB) crossed above their 200 day moving average of $39.58, changing hands as high as $39.70 per share. Genmab A/S shares are currently trading up about 2.2% on the day. The chart below shows the one year performance of GMAB
(www.nasdaq.com)
-
lahn1. synes nu, at dit indlæg 21:55 var bedst
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind